Investment in Unconsolidated Entities (Tables)

12 Months Ended

Dec. 31, 2015

Neuro Partners LLC and CGK [Member]

Schedule of Equity Method Investments [Line Items]

Summarized Financial Information

The following tables present the aggregation of summarized financial information of NeuroPartners LLC and CGK:

Neuro Partners LLC and CGK Combined Condensed Income Statement Information
	Year Ended
	December 31,
	2015			2014
Patient revenue	$	912,000		$	1,223,000
Net (loss) income	$	(184,000	)	$	74,000
USNC's equity in (loss) income of Neuro Partners LLC and CGK	$	(84,000	)	$	14,000
Neuro Partners LLC and CGK Combined Condensed Balance Sheet Information
	December 31,
		2015			2014
Current assets	$	66,000		$	92,000
Noncurrent assets		394,000			991,000
Total assets	$	460,000		$	1,083,000
Current liabilities	$	1,359,000		$	829,000
Noncurrent liabilities		-			969,000
Equity		(899,000	)		(715,000	)
Total liabilities and equity	$	460,000		$	1,083,000

FOP and FOPRE [Member]

Schedule of Equity Method Investments [Line Items]

Summarized Financial Information

The following tables present the aggregation of summarized financial information of FOP and FOPRE:

FOP and FOPRE Combined Condensed Income Statement Information
	Year Ended December 31,
	2015		2014
Revenue	$	3,157,000	$	2,631,000
Net income	$	1,344,000	$	197,000
USNC's equity in income of FOP and FOPRE	$	323,000	$	39,000
FOP and FOPRE Combined Condensed Balance Sheet Information
	December 31,
		2015		2014
Current assets	$	1,024,000	$	606,000
Noncurrent assets		3,066,000		5,070,000
Total assets	$	4,090,000	$	5,676,000
Current liabilities	$	1,848,000	$	858,000
Noncurrent liabilities		1,529,000		3,947,000
Equity		713,000		871,000
Total liabilities and equity	$	4,090,000	$	5,676,000

BOP and BOPRE [Member]

Schedule of Equity Method Investments [Line Items]

Summarized Financial Information

The following tables present the summarized financial information of BOP and BOPRE:

BOP Condensed Income Statement Information
	Year Ended December 31,
	2014
Patient revenue	$	115,000
Net loss	$	(108,000	)
USNC's equity in loss in BOP	$	(12,000	)

BOPRE Condensed Income Statement Information
	Years Ended December 31,
	2015		2014
Rental Income	$	3,000	$	-
Net income (loss)	$	3,000	$	(4,000	)
USNC's equity in loss in BOPRE	$	-	$	-
BOPRE Condensed Balance Sheet Information
	December 31,
		2015		2014
Current assets	$	40,000	$	61,000
Noncurrent assets		837,000		786,000
Total assets	$	877,000	$	847,000
Current liabilities	$	-	$	-
Noncurrent liabilities		-		-
Equity		877,000		847,000
Total liabilities and equity	$	877,000	$	847,000

Broward Oncology Partners, LLC [Member]

Schedule of Equity Method Investments [Line Items]

Summarized Financial Information

Broward Oncology Partners, LLC Condensed Income Statement Information
	Year Ended December 31, 2014
Patient revenue	$	505,000
Net income (loss)	$	255,000
USNC's equity in income (loss) of Broward Oncology Partners	$	32,000